Call us: +202 22 905 906
E-Mail: mail@alpha-pharmaceuticals.com
You are here
National Institutes of Health (NIH)
NIH findings highlight critical gaps in treatment access in correctional facilities, where almost two-thirds of people have a substance use disorder.
NIH-funded analysis suggests higher doses of buprenorphine were associated with lower rates of future behavioral health-related emergency department and inpatient care.
NIH takes very seriously allegations of research misconduct.
NIH-supported findings pave the way for genetic testing, clinical trials, and therapy development.
NIH-supported milestone will advance understanding of brain processes in larger animals.
Effort to identify risk factors for youth-onset type 2 diabetes to improve prevention and treatment.
NIH-funded study focused on original virus strain, unvaccinated participants during pandemic.
NIH-funded brain mapping study uncovers which cell types may be harmed first.
Commentary emphasizes that engagement across stakeholders is critical to accelerate smoking cessation and reduce smoking-related disease and death.
NIH clinical trial addresses knowledge gap on vaccine use in adolescent populations